The Remarried Empress Teaser Unveils a Royal Battle of Love and Power

India, Aug. 27 -- Disney+ has unveiled the first teaser for The Remarried Empress, bringing together Shin Min Ah, Ju Ji Hoon, Lee Jong Suk and Lee Se Young in a grand fantasy romance set against the b... Read More

Government seeks conducive atmosphere for Jakarta demonstrations

Jakarta, Aug. 27 -- The government remains committed to safeguarding public safety and order as citizens rally in Jakarta to voice their aspirations to the House of Representatives (DPR), Coordinating... Read More

Dolly Parton's Business Legacy Extended Far Beyond Music

India, Aug. 27 -- Country music icon Dolly Parton turned her creative success into a vast business portfolio, building wealth through music rights, entertainment ventures and investments while also su... Read More

Customs detect bid to import 4 luxury cars as used parts

Dhaka, Aug. 27 -- Customs intelligence officials have uncovered an attempt to import four luxury cars into Bangladesh by declaring their major components separately as 'used car parts' and cutting the... Read More

Fino Payments Bank gets RBI nod for extension of tenure of Ketan Merchant as interim CEO

Mumbai, Aug. 27 -- The extension would be effective from 27 August 2026 or till the date of taking charge of regular MD & CEO, whichever is earlier. The announcement was made post market hours yester... Read More

Singapore Clinical Trial: DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PLOZASIRAN IN ADULTS WITH SEVERE HYPERTRIGLYCERIDEMIA AT HIGH RISK OF ACUTE PANCREATITIS (SHASTA-5 STUDY)

Singapore, Aug. 27 -- The Health Sciences Authority received information related to the study titled 'DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PLOZASIRAN ... Read More

Singapore Clinical Trial: A Phase 3 Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) versus Treatment of Investigator’s Choice (IC) in Patients with Endometrial Cancer After Platinum-Based Chemotherapy and PD(L)-1 Therapy

Singapore, Aug. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) versus Treatment of Invest... Read More

Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, Aug. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) M... Read More

Singapore Clinical Trial: A Multicenter, Randomized, Double-blind, Phase 2/3 Study of Ficerafusp Alfa (BCA101) or Placebo in Combination with Pembrolizumab for First-Line Treatment of PD-L1-positive, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Singapore, Aug. 27 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Randomized, Double-blind, Phase 2/3 Study of Ficerafusp Alfa (BCA101) or Placebo in... Read More

Singapore Clinical Trial: Safety, immunogenicity and efficacy of low dose Nivolumab in adults living with HIV on antiretroviral therapy (ART): NIVO-LD

Singapore, Aug. 27 -- The Health Sciences Authority received information related to the study titled 'Safety, immunogenicity and efficacy of low dose Nivolumab in adults living with HIV on antiretrovi... Read More

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »
• »»